The successful completion of this procedure brings Neuralink one step closer to launching its first product, Telepathy, which it claims will allow users to control devices such as smartphones and computers through thought.
“As the materials and electrode designs used for neurotechnology continue to evolve, the hope is that these solutions will improve the quality of life for patients,” says Ho.
The surgery by Neuralink comes just months after the company revealed it had received regulatory approval to test its brain chips in humans.
Neuralink has faced significant criticism for conducting medical research involving trials of its chip on live monkeys, resulting in the deaths of roughly 1,500 animals between 2018 and 2022. The company has been working for half a decade to use implants to connect the human brain to a computer.
According to a Reuters report in 2022, the company tried…
